Asia Pacific Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Allergy Immunotherapy Market would witness market growth of 9.4% CAGR during the forecast period (2023-2030).

Recent years have seen a substantial increase in interest in the immunotherapy treatment industry because of its novel approach to cancer treatment. It's crucial to remember that an expanding sector for allergy immunotherapy uses comparable immunotherapy techniques to treat allergies. Immunotherapy for allergies differs from immunotherapy for cancer, although there are some parallels between the two. Both utilize biologics to activate an immunological response while depending on the immune system to combat disease. The success of cancer immunotherapies has also generated interest in using comparable strategies for treating other disease states, including allergies.

This market is one of the fastest-growing segments in the healthcare sector, with various variables influencing the current environment. The expanding incidence of allergies, developments in biotechnology and immunology, and the demand for individualized medication are all significant incentives. Among other things, allergy immunotherapy is a medication that stops allergic reactions from food, grass pollen, dust, and bee venom. Allergy immunotherapy aids in the reduction of allergy symptoms, particularly those that frequently lead to rhinitis, asthma, and conjunctivitis.

The National Library of Medicine reports that in China, 10.54% and 9.99% of patients, respectively, self-reported having food and medication allergies. Additionally, 20.48% of patients overreacted to insect bites. India is experiencing a fast health transition, with the rising burden of non-communicable disease (NCD) surpassing the burden of communicable disease. For the prevention and control of NCDs, many programs by the government were launched with a focus on strengthening infrastructure, human resources, early diagnosis, referral, and management. The rising cases of non-communicable diseases with the increasing government programs for their treatment will further surge the market's growth.

The China market dominated the Asia Pacific Allergy Immunotherapy Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $208.9 million by 2030. The Japan market is poised to grow at a CAGR of 8.7% during (2023 - 2030). Additionally, The India market would register a CAGR of 10.1% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Treatment Type, the market is segmented into Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT) (Tablets, and Drops). Based on Allergy Type, the market is segmented into Allergic Rhinitis, Allergic Asthma, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc. (Mylan N.V.), Merck KGaA , NIOX Group plc , DMS Imaging SA, Adamis Pharmaceuticals Corporation, Stallergenes Greer International AG (B-Flexion), Allergy Therapeutics plc , DBV Technologies S.A., HAL Allergy B.V. (Droege International Group AG.), LETI Pharma, S.L.U.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy

By Treatment Type

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
- Tablets
- Drops

By Allergy Type

Allergic Rhinitis
Allergic Asthma
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Viatris, Inc. (Mylan N.V.)
Merck KGaA
NIOX Group plc
DMS Imaging SA
Adamis Pharmaceuticals Corporation
Stallergenes Greer International AG (B-Flexion)
Allergy Therapeutics plc
DBV Technologies S.A.
HAL Allergy B.V. (Droege International Group AG.)
LETI Pharma, S.L.U.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Allergy Immunotherapy Market, by Distribution Channel
- 1.4.2 Asia Pacific Allergy Immunotherapy Market, by Treatment Type
- 1.4.3 Asia Pacific Allergy Immunotherapy Market, by Allergy Type
- 1.4.4 Asia Pacific Allergy Immunotherapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance

2.1 Key Highlight

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. Asia Pacific Allergy Immunotherapy Market by Distribution Channel

4.1 Asia Pacific Retail Pharmacy Market by Country
4.2 Asia Pacific Hospital Pharmacy Market by Country
4.3 Asia Pacific Online Pharmacy Market by Country

Chapter 5. Asia Pacific Allergy Immunotherapy Market by Treatment Type

5.1 Asia Pacific Subcutaneous Immunotherapy (SCIT) Market by Country
5.2 Asia Pacific Sublingual Immunotherapy (SLIT) Market by Country
5.3 Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 5.3.1 Asia Pacific Tablets Market by Country
- 5.3.2 Asia Pacific Drops Market by Country

Chapter 6. Asia Pacific Allergy Immunotherapy Market by Allergy Type

6.1 Asia Pacific Allergic Rhinitis Market by Country
6.2 Asia Pacific Allergic Asthma Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Allergy Immunotherapy Market by Country

7.1 China Allergy Immunotherapy Market
- 7.1.1 China Allergy Immunotherapy Market by Distribution Channel
- 7.1.2 China Allergy Immunotherapy Market by Treatment Type
  - 7.1.2.1 China Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.1.3 China Allergy Immunotherapy Market by Allergy Type
7.2 Japan Allergy Immunotherapy Market
- 7.2.1 Japan Allergy Immunotherapy Market by Distribution Channel
- 7.2.2 Japan Allergy Immunotherapy Market by Treatment Type
  - 7.2.2.1 Japan Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.2.3 Japan Allergy Immunotherapy Market by Allergy Type
7.3 India Allergy Immunotherapy Market
- 7.3.1 India Allergy Immunotherapy Market by Distribution Channel
- 7.3.2 India Allergy Immunotherapy Market by Treatment Type
  - 7.3.2.1 India Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.3.3 India Allergy Immunotherapy Market by Allergy Type
7.4 South Korea Allergy Immunotherapy Market
- 7.4.1 South Korea Allergy Immunotherapy Market by Distribution Channel
- 7.4.2 South Korea Allergy Immunotherapy Market by Treatment Type
  - 7.4.2.1 South Korea Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.4.3 South Korea Allergy Immunotherapy Market by Allergy Type
7.5 Singapore Allergy Immunotherapy Market
- 7.5.1 Singapore Allergy Immunotherapy Market by Distribution Channel
- 7.5.2 Singapore Allergy Immunotherapy Market by Treatment Type
  - 7.5.2.1 Singapore Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.5.3 Singapore Allergy Immunotherapy Market by Allergy Type
7.6 Malaysia Allergy Immunotherapy Market
- 7.6.1 Malaysia Allergy Immunotherapy Market by Distribution Channel
- 7.6.2 Malaysia Allergy Immunotherapy Market by Treatment Type
  - 7.6.2.1 Malaysia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.6.3 Malaysia Allergy Immunotherapy Market by Allergy Type
7.7 Rest of Asia Pacific Allergy Immunotherapy Market
- 7.7.1 Rest of Asia Pacific Allergy Immunotherapy Market by Distribution Channel
- 7.7.2 Rest of Asia Pacific Allergy Immunotherapy Market by Treatment Type
  - 7.7.2.1 Rest of Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.7.3 Rest of Asia Pacific Allergy Immunotherapy Market by Allergy Type

Chapter 8. Company Profiles

8.1 Viatris, Inc. (Mylan N.V.)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Merck KGaA
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 NIOX Group plc
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 DMS Imaging SA
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 SWOT Analysis
8.5 Adamis Pharmaceuticals Corporation
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 SWOT Analysis
8.6 Stallergenes Greer International AG (B-Flexion)
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
  - 8.6.2.1 Partnerships, Collaborations, and Agreements:
  - 8.6.2.2 Acquisition and Mergers:
- 8.6.3 SWOT Analysis
8.7 Allergy Therapeutics plc
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
8.8 DBV Technologies S.A.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Research & Development Expenses
- 8.8.4 SWOT Analysis
8.9 HAL Allergy B.V. (Droege International Group AG.)
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
8.10. LETI Pharma, S.L.U.
- 8.10.1 Company Overview

LIST OF TABLES

TABLE 1 Asia Pacific Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Subcutaneous Immunotherapy (SCIT) Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Subcutaneous Immunotherapy (SCIT) Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Sublingual Immunotherapy (SLIT) Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Sublingual Immunotherapy (SLIT) Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Tablets Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Tablets Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Drops Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Drops Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Allergic Rhinitis Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Allergic Rhinitis Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Allergic Asthma Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Allergic Asthma Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Allergy Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Allergy Immunotherapy Market by Country, 2023 - 2030, USD Million
TABLE 33 China Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 34 China Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 35 China Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 China Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 China Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 38 China Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 39 China Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 40 China Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 41 China Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 42 China Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 43 Japan Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 44 Japan Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 45 Japan Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Japan Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Japan Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 48 Japan Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 49 Japan Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 50 Japan Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 51 Japan Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 52 Japan Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 53 India Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 54 India Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 55 India Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 India Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 India Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 58 India Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 59 India Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 60 India Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 61 India Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 62 India Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 63 South Korea Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 64 South Korea Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 65 South Korea Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 South Korea Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 South Korea Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 68 South Korea Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 69 South Korea Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 70 South Korea Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 71 South Korea Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 72 South Korea Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 73 Singapore Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 74 Singapore Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 75 Singapore Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Singapore Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Singapore Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 78 Singapore Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 79 Singapore Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 80 Singapore Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 81 Singapore Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 82 Singapore Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 83 Malaysia Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 84 Malaysia Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 85 Malaysia Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Malaysia Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 87 Malaysia Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 88 Malaysia Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 89 Malaysia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 90 Malaysia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 91 Malaysia Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 92 Malaysia Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 93 Rest of Asia Pacific Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 94 Rest of Asia Pacific Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 95 Rest of Asia Pacific Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 96 Rest of Asia Pacific Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 97 Rest of Asia Pacific Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 98 Rest of Asia Pacific Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 99 Rest of Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 100 Rest of Asia Pacific Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 101 Rest of Asia Pacific Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 102 Rest of Asia Pacific Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 103 key information - Viatris, Inc.
TABLE 104 key Information - Merck KGaA
TABLE 105 Key Information - NIOX Group plc
TABLE 106 Key Information - DMS Imaging SA
TABLE 107 Key Information - Adamis Pharmaceuticals Corporation
TABLE 108 Key Information - Stallergenes Greer International AG
TABLE 109 Key Information - Allergy Therapeutics plc
TABLE 110 Key Information - DBV TECHNOLOGIES S.A.
TABLE 111 Key Information - HAL Allergy B.V.
TABLE 112 Key Information - LETI Pharma, S.L.U.

List of Figures

FIG 1 Methodology for the research
FIG 2 Asia Pacific Allergy Immunotherapy Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Allergy Immunotherapy Market
FIG 4 Porter's Five Forces Analysis - Allergy Immunotherapy Market
FIG 5 Asia Pacific Allergy Immunotherapy Market share by Distribution Channel, 2022
FIG 6 Asia Pacific Allergy Immunotherapy Market share by Distribution Channel, 2030
FIG 7 Asia Pacific Allergy Immunotherapy Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Asia Pacific Allergy Immunotherapy Market share by Treatment Type, 2022
FIG 9 Asia Pacific Allergy Immunotherapy Market share by Treatment Type, 2030
FIG 10 Asia Pacific Allergy Immunotherapy Market by Treatment Type, 2019 - 2030, USD Million
FIG 11 Asia Pacific Allergy Immunotherapy Market share by Allergy Type, 2022
FIG 12 Asia Pacific Allergy Immunotherapy Market share by Allergy Type, 2030
FIG 13 Asia Pacific Allergy Immunotherapy Market by Allergy Type, 2019 - 2030, USD Million
FIG 14 Asia Pacific Allergy Immunotherapy Market share by Country, 2022
FIG 15 Asia Pacific Allergy Immunotherapy Market share by Country, 2030
FIG 16 Asia Pacific Allergy Immunotherapy Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Viatris, Inc.
FIG 18 Swot Analysis: Merck KGaA
FIG 19 SWOT Analysis: NIOX Group plc
FIG 20 SWOT Analysis: DMS Imaging SA
FIG 21 SWOT Analysis: Adamis Pharmaceuticals Corporation
FIG 22 Recent strategies and developments: Stallergenes Greer International AG
FIG 23 SWOT Analysis: Stallergenes Greer International AG
FIG 24 SWOT Analysis: Allergy Therapeutics plc
FIG 25 SWOT Analysis: DBV Technologies S.A.
FIG 26 SWOT Analysis: HAL Allergy B.V.

Asia Pacific Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents